Abiopharma

News list

Rosenthal Brent D 🟡 adjusted position in 0 shares (1 derivative) of PITNEY BOWES INC /DE/ (PBI) Transaction Date: Jun 18, 2026 | Filing ID: 000003

Full text

News bot June 22, 2026, 7:11 p.m.
🔍 Rosenthal Brent D (Executive)

Company: PITNEY BOWES INC /DE/ (PBI)

Report Date: 2026-06-18
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 8,755
- Total shares sold: 8,755
Detailed Transactions and Holdings:
- Acquired 8,755 shares of Common Stock (Direct)
  Date: 2026-06-18 | Code: M | equity_swap_involved: false | shares_owned_after: 17,755.00 | transaction_form_type: 4
- Sold 8,755 shares of Restricted Stock Unit (Derivative)
  Date: 2026-06-18 | Code: M | equity_swap_involved: false | shares_owned_after: 24,691.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each unit represents a contingent right to receive one share of Pitney Bowes common stock.
- F2: Restricted Stock Units granted to non-employee directors on June 18, 2025 cliff vested according to schedule on June 18, 2026.